Tuesday, January 29, 2013 Monday, January 28, 2013- Keryx: This Biotech Is No Zombieat Motley Fool (Mon, Jan 28)
- Illumina posts gain in 4Q on business unit saleAP (Mon, Jan 28)
- Amgen Rises On Unusually High Volume (AMGN)at TheStreet (Mon, Jan 28)
- Keryx Rises on Results of Phosphorous-Lowering Drug Studyat Bloomberg (Mon, Jan 28)
- Statins Beware?at Motley Fool (Mon, Jan 28)
- Statins Beware?at Motley Fool (Mon, Jan 28)
- Kudos To Keryx, But Can Zerenex Zing?at TheStreet (Mon, Jan 28)
- Amgen's Neulasta Succeeds in Phase 3 Cancer Trialat Motley Fool (Mon, Jan 28)
- The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead Sciences, Vertex Pharmaceuticals and Nasdaq Biotechnology Index ETFZacks (Mon, Jan 28)
Saturday, January 26, 2013 Friday, January 25, 2013 Thursday, January 24, 2013Add AMGN News to My Yahoo!  | |
|